Latest goodwill for EGTX.ST: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Egetis Therapeutics AB (publ) (EGTX.ST) currently reports a goodwill of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Egetis Therapeutics AB (publ)'s goodwill history and peer comparisons.
Egetis Therapeutics AB (publ)'s goodwill changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Egetis Therapeutics AB (publ) reported $0 in goodwill as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Egetis Therapeutics AB (publ), and consider following EGTX.ST for alerts when major investors trade the stock.
Egetis Therapeutics AB (publ) is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EGTX.ST with unrelated industries.